Drug Markets/DORAVIRINE, LAMIVUDINE, AND TENOFOVIR DISOPROXIL FUMARATE

DORAVIRINE, LAMIVUDINE, AND TENOFOVIR DISOPROXIL FUMARATE

1 NDCs across 1 manufacturers|0 Generic,1 Brand

Total NDCs

0G / 1B

Manufacturers

competing in market

Price Spread

$92.91 – $92.91

7d Activity

1 flat

of 1 total NDCs

Monthly average NADAC price per unit, split by generic and brand

1 manufacturer producing DORAVIRINE, LAMIVUDINE, AND TENOFOVIR DISOPROXIL FUMARATE

1 NDCs total, 1 shown

Drug ↕	NDC	Manufacturer ↕	Price	Market Outlier	Class	7d Change ↕	Therapeutic Class
DELSTRIGO 100-300-300 MG TAB	00006500701	Merck Sharp & Dohme LLC	$92.9143 per EA	—	Brand	—	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor